Oakbrook Investments LLC cut its stake in shares of Colgate-Palmolive (NYSE:CL) by 6.6% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 63,250 shares of the company’s stock after selling 4,450 shares during the period. Oakbrook Investments LLC’s holdings in Colgate-Palmolive were worth $4,608,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Blue Chip Partners Inc. raised its stake in Colgate-Palmolive by 0.4% during the 2nd quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock valued at $134,000 after acquiring an additional 8 shares during the last quarter. Cue Financial Group Inc. raised its stake in Colgate-Palmolive by 0.3% during the 2nd quarter. Cue Financial Group Inc. now owns 4,854 shares of the company’s stock valued at $360,000 after acquiring an additional 14 shares during the last quarter. M Holdings Securities Inc. raised its stake in Colgate-Palmolive by 0.4% during the 1st quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock valued at $393,000 after acquiring an additional 21 shares during the last quarter. AlphaMark Advisors LLC raised its stake in Colgate-Palmolive by 1.5% during the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after acquiring an additional 25 shares during the last quarter. Finally, Capital Investment Advisors LLC raised its stake in Colgate-Palmolive by 0.3% during the 2nd quarter. Capital Investment Advisors LLC now owns 8,318 shares of the company’s stock valued at $617,000 after acquiring an additional 27 shares during the last quarter. 72.96% of the stock is owned by hedge funds and other institutional investors.

In related news, Director Stephen I. Sadove sold 20,780 shares of the firm’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $70.52, for a total value of $1,465,405.60. Following the completion of the transaction, the director now directly owns 36,268 shares of the company’s stock, valued at approximately $2,557,619.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Victoria L. Dolan sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the completion of the transaction, the insider now directly owns 60,528 shares of the company’s stock, valued at $4,422,780.96. The disclosure for this sale can be found here. Over the last three months, insiders have sold 181,048 shares of company stock valued at $13,168,995. Company insiders own 1.02% of the company’s stock.

CL has been the subject of several analyst reports. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price objective for the company in a research note on Monday, September 25th. SunTrust Banks raised Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price objective for the company from $65.00 to $85.00 in a research note on Wednesday, October 11th. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Royal Bank of Canada reaffirmed a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a research note on Sunday, October 8th. Finally, Jefferies Group reaffirmed a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research note on Thursday, September 28th. Two equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $76.04.

Colgate-Palmolive (CL) opened at $74.05 on Friday. The stock has a market capitalization of $64,312.43, a P/E ratio of 25.52, a PEG ratio of 3.35 and a beta of 0.81. Colgate-Palmolive has a one year low of $63.43 and a one year high of $77.27. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.73. The business had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.73 EPS. research analysts anticipate that Colgate-Palmolive will post 2.88 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Colgate-Palmolive (CL) Shares Sold by Oakbrook Investments LLC” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/12/16/colgate-palmolive-cl-shares-sold-by-oakbrook-investments-llc.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related stocks with our FREE daily email newsletter.